Positive predictive values of the coding for bisphosphonate therapy among cancer patients in the Danish National Patient Registry

Clinical Epidemiology

Volumn 4, Issue 1, 2012, Pages 233-236

  Nielsson, Malene Schou ^a   Erichsen, Rune ^a   Frøslev, Trine ^a   Taylor, Aliki ^b   Acquavella, John ^b   Ehrenstein, Vera ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AMGEN INC   (United States)

Author keywords

Bisphosphonate; Neoplasm metastases; Predictive value of tests; Validation studies

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID; ZOLEDRONIC ACID;

ADULT; AGED; BONE METASTASIS; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGISTRY; CONTROLLED STUDY; DANISH; ETHNIC GROUP; FEMALE; HUMAN; KIDNEY CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD; MULTIPLE MYELOMA; OSTEOPOROSIS; PREDICTIVE VALUE; PROSTATE CANCER; REVIEW; TREATMENT RESPONSE; VALIDATION PROCESS;

EID: 84866015654     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/clep.s32868     Document Type: Review

References (15)

1. Wilkinson AN, Viola R, Brundage MD. Managing skeletal related events resulting from bone metastases. BMJ. 2008;337:a2041.
2. Jensen AO, Jacobsen JB, Nørgaard M, Yong M, Fryzek JP, Sørensen HT. Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark. BMC Cancer. 2011;11:29.
3. Coleman RE, McCloskey EV. Bisphosphonates in oncology. Bone. 2011;49(1):71-76.
4. Erichsen R, Christiansen CF, Frøslev T, Jacobsen J, Sørensen HT. Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study. Br J Cancer. 2011; 105(7):881-883.
5. Shannon J, Shannon J, Modelevsky S, Grippo AA. Bisphosphonates and osteonecrosis of the jaw. J Am Geriatr Soc. 2011;59(12): 2350-2355.
6. Bonomi M, Nortilli R, Molino A, et al. Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis. Med Oncol. 2010;27(2):224-229.
7. Andersen TF, Madsen M, Jørgensen J, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46(3):263-268.
8. Nickelsen TN. Data validity and coverage in the Danish National Health Registry. A literature review. Ugeskr Laeger. 2001;164(1):33-37. Danish.
9. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83.
10. Severinsen MT, Kristensen SR, Overvad K, Dethlefsen C, Tjønneland A, Johnsen SP. Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol. 2010;63(2):223-228.
11. Brown LD, Cai TT, DasGupta A. Interval estimation for a binomial proportion. Statistical Science. 2001;16:101-133.
12. Mosbech J, Jørgensen J, Madsen M, Rostgaard K, Thornberg K, Poulsen TD. The national patient registry. Evaluation of data quality. Ugeskr Laeger. 1995;157(26):3741-3745. Danish.
13. Erichsen R, Sværke C, Tøttrup A. The coding quality of acute total colectomy in inflammatory bowel disease patients in a nationwide hospital registry. Pharmacoepidemiol Drug Saf. 2011;20 Suppl S1: S165.
14. Sorensen HT, Sabroe S, Olsen J. A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol. 1996;25(2):435-442.
15. Baron JA, Weiderpass E. An introduction to epidemiological research with medical databases. Ann Epidemiol. 2000;10(4):200-204.